JPRN-UMIN000006583已完成2 期
Multicancer Phase II study of mFOLFOX6 as Neoadjuvant chemotherapy for T3 or T4 Stage II / III rectal cancer - Phase II study of mFOLFOX6 as Neoadjuvant chemotherapy for rectal cancer (FACT)
Tokyo Women's Medical University Hospital0 个研究点目标入组 50 人开始时间: 2011年10月21日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. Comorbidity of active double cancer 2. Peripheral sensory nerve disorder 3. Poor controled hypertension 4. Poor controled diabetes mellitus 5. Severe electrocardiographic abnormality or comorbidity of poor controled heart failure 6. Comorbidity of severe pulmonary diease (interstitial lung disease, pulmonary fibrosis, emphysema pulmonum and so on) 7. Poor controlled psychiatric disorder or history of central nervous system disorder 8. Watery diarrhea 9. Treated continuously with systemic steroids 10. Pregnant or lactating women or women childbearing potential 11. Any other cases who are regarded as inadequate for study enrollment by the investigator.
研究者
相似试验
已完成
2 期
Phase II trial of adjuvant mFOLFOX6 after metastasectomy for lung metastasis of colorectal cancerColorectal cancerJPRN-UMIN000005693West Japan Oncology Group100
已完成
2 期
Feasibility study of neoadjuvant mFOLFOX6 plus cetuximab in patients with resectable liver limited metastases from colorectal cancer harboring KRAS wild typeMetastatic colorectal cancerJPRN-UMIN000007545ational Cancer Center Hospital East20
已完成
2 期
Phase II study of neoadjuvant mFOLFOX6 (+ cetuximab) in patients with resectable pelvic recurrences after rectal cancer surgeryRecurrent rectal cancerJPRN-UMIN000009583ational Cancer Center Hospital East33
已完成
2 期
PhaseII study of mFOLFOX6 in gastric cancer refractory to standard therapyGastric cancerJPRN-UMIN000016416Aichi Cancer Center Hospital35
已完成
2 期
Multicenter phase II study of modified FOLFOX6 and bevacizumab in chemonaive advanced or recurrent colorectal cancer.Colorectal CancerJPRN-UMIN000001490Yakult Honsha Co.,Ltd.65